11 studies found for:    (NCCAM) [SPONSOR-COLLABORATORS] (liver disease) [CONDITION]
Show Display Options
Rank Status Study
1 Terminated The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
Conditions: Fatty Liver;   Hepatic Steatosis;   Diabetes Mellitus;   Liver Diseases
Intervention: Drug: Probiotic-containing powder
2 Completed Phase I Trial of Silymarin for Chronic Liver Diseases
Conditions: Hepatitis C;   Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Placebo;   Drug: Silymarin
3 Withdrawn Treatment of Alcohol-Related Hepatitis With Arginine
Condition: Alcoholic Hepatitis
Intervention: Drug: Arginine
4 Completed Herbal Treatment of Hepatitis C in Methadone Maintained Patients
Condition: Hepatitis C
Intervention: Drug: Herbal remedies
5 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
6 Completed Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Condition: Chronic Hepatitis C
Interventions: Drug: Silymarin;   Other: Placebo
7 Completed IdB 1016 Treatment for Hepatitis C Disease
Condition: Hepatitis C, Chronic
Intervention: Drug: IdB 1016
8 Completed Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Biological: Lactobacillus GG;   Biological: Placebo
9 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
10 Completed Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Oxidative Stress
Interventions: Drug: silymarin;   Dietary Supplement: green tea extract (EGCG)
11 Withdrawn Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes
Condition: Hepatitis C
Intervention: Drug: Interferon-alpha

Indicates status has not been verified in more than two years